Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy

Por Lotan, Tamara L., Epstein, Jonathan I.
Publicado em 2009

mTOR Signaling Feedback Modulates Mammary Epithelial Differentiation and Restrains Invasion Downstream of PTEN Loss

Por Ghosh, Susmita, Varela, Lidenys, Sood, Akshay, Park, Ben Ho, Lotan, Tamara L.
Publicado em 2013

Estrogen-Dependent and -Independent Estrogen Receptor-α Signaling Separately Regulate Male Fertility

Por Sinkevicius, Kerstin W., Laine, Muriel, Lotan, Tamara L., Woloszyn, Karolina, Richburg, John H., Greene, Geoffrey L.
Publicado em 2009

Immunohistochemical Panel to Identify the Primary Site of Invasive Micropapillary Carcinoma

Por Lotan, Tamara L., Ye, Huihui, Melamed, Jonathan, Wu, Xue-Ru, Shih, Ie-Ming, Epstein, Jonathan I.
Publicado em 2009

Tight correlation of 5-hydroxymethylcytosine and Polycomb marks in health and disease

Por Haffner, Michael C., Pellakuru, Laxmi G., Ghosh, Susmita, Lotan, Tamara L., Nelson, William G., De Marzo, Angelo M., Yegnasubramanian, Srinivasan
Publicado em 2013

Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia

Por Lotan, Tamara L., Gumuskaya, Berrak, Rahimi, Hameed, Hicks, Jessica L., Iwata, Tsuyoshi, Robinson, Brian D., Epstein, Jonathan I., De Marzo, Angelo M.
Publicado em 2012

PI3K/mTOR Signaling Regulates Prostatic Branching Morphogenesis

Por Ghosh, Susmita, Lau, Hiu, Simons, Brian W., Powell, Jonathan D., Meyers, David J., De Marzo, Angelo M., Berman, David M., Lotan, Tamara L.
Publicado em 2011

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

Por Andreas, Darian, Tosoian, Jeffrey J., Landis, Patricia, Wolf, Sacha, Glavaris, Stephanie, Lotan, Tamara L., Schaeffer, Edward M., Sokoll, Lori J., Ross, Ashley E.
Publicado no Urol Case Rep (2016)

PTEN loss and ERG Protein Expression are Infrequent in Prostatic Ductal Adenocarcinomas and Concurrent Acinar Carcinomas

Por Morais, Carlos L., Herawi, Mehsati, Toubaji, Antoun, Albadine, Roula, Hicks, Jessica, Netto, George J., De Marzo, Angelo M., Epstein, Jonathan I., Lotan, Tamara L.
Publicado no Prostate (2015)

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

Por Gumuskaya, Berrak, Gurel, Bora, Fedor, Helen, Tan, Hsueh-Li, Weier, Christopher A., Hicks, Jessica L., Haffner, Michael C., Lotan, Tamara L., Marzo, Angelo M. De
Publicado em 2013

Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

Por Epstein, Jonathan I., Amin, Mahul B., Beltran, Himisha, Lotan, Tamara L., Mosquera, Juan-Miguel, Reuter, Victor E., Robinson, Brian D., Troncoso, Patricia, Rubin, Mark A.
Publicado em 2014

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas

Por Lotan, Tamara L, Toubaji, Antoun, Albadine, Roula, Latour, Mathieu, Herawi, Mehsati, Meeker, Alan K, DeMarzo, Angelo M, Platz, Elizabeth A, Epstein, Jonathan I, Netto, George J
Publicado em 2009

An Immunohistochemical Signature Comprising PTEN, MYC, and Ki67 Predicts Progression in Prostate Cancer Patients Receiving Adjuvant Docetaxel After Prostatectomy

Por Antonarakis, Emmanuel S., Keizman, Daniel, Zhang, Zhe, Gurel, Bora, Lotan, Tamara L., Hicks, Jessica L., Fedor, Helen L., Carducci, Michael A., De Marzo, Angelo M., Eisenberger, Mario A.
Publicado em 2012

PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for Active Surveillance

Por Trock, Bruce J., Fedor, Helen, Gurel, Bora, Jenkins, Robert B., Knudsen, BS, Fine, Samson W., Said, Jonathan W., Carter, H. Ballentine, Lotan, Tamara L., De Marzo, Angelo M.
Publicado no Mod Pathol (2016)

Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

Por Faisal, Farzana A., Sundi, Debasish, Tosoian, Jeffrey J., Choeurng, Voleak, Alshalalfa, Mohammed, Ross, Ashley E., Klein, Eric, Den, Robert, Dicker, Adam, Erho, Nicholas, Davicioni, Elai, Lotan, Tamara L., Schaeffer, Edward M.
Publicado no Eur Urol (2015)

ERG gene rearrangements are common in prostatic small cell carcinomas

Por Lotan, Tamara L, Gupta, Nilesh S, Wang, Wenle, Toubaji, Antoun, Haffner, Michael C, Chaux, Alcides, Hicks, Jessica L, Meeker, Alan K, Bieberich, Charles J, De Marzo, Angelo M, Epstein, Jonathan I, Netto, George J
Publicado em 2011

PTEN Loss is Associated with Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy

Por Lotan, Tamara L., Carvalho, Filipe LF., Peskoe, Sarah B., Hicks, Jessica L., Good, Jennifer, Fedor, Helen, Humphreys, Elizabeth, Han, Misop, Platz, Elizabeth A., Squire, Jeremy A., De Marzo, Angelo M., Berman, David M.
Publicado no Mod Pathol (2014)

Utility of PTEN and ERG Immunostaining for Distinguishing High Grade PIN and Intraductal Carcinoma of the Prostate on Needle Biopsy

Por Morais, Carlos L., Han, Jeong S., Gordetsky, Jennifer, Nagar, Michael S., Anderson, Ann E., Lee, Stephen, Hicks, Jessica L., Zhou, Ming, Magi-Galluzzi, Cristina, Shah, Rajal B., Epstein, Jonathan I., De Marzo, Angelo M., Lotan, Tamara L.
Publicado no Am J Surg Pathol (2015)

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

Por Lotan, Tamara L., Gurel, Bora, Sutcliffe, Siobhan, Esopi, David, Liu, Wennuan, Xu, Jianfeng, Hicks, Jessica L., Park, Ben H., Humphreys, Elizabeth, Partin, Alan W., Han, Misop, Netto, George J., Isaacs, William B., De Marzo, Angelo M.
Publicado em 2011

Rb Loss is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

Por Tan, Hsueh-Li, Sood, Akshay, Rahimi, Hameed A., Wang, Wenle, Gupta, Nilesh, Hicks, Jessica, Mosier, Stacy, Gocke, Christopher D., Epstein, Jonathan I., Netto, George J., Liu, Wennuan, Isaacs, William B., De Marzo, Angelo M., Lotan, Tamara L.
Publicado em 2013